Search results
Results from the WOW.Com Content Network
Here are some common signs of stress-induced hair loss in females: Shedding more than 100 hairs a day (typically losing 50-100 is common) Seeing diffused thinning and more scalp peeking through ...
Hair loss is extremely common among women. Female pattern hair loss, for example, affects about 30 million women in the United States and many adults experience telogen effluvium at some point in ...
The same review also showed the prevalence of hair loss increases with age — approximately 12 percent of women aged 20 and 29 years experience hair loss, while over 50 percent of women over the ...
Amphetamine was discovered as a chemical in 1887 by Lazăr Edeleanu, and then as a drug in the late 1920s. It exists as two enantiomers: [note 3] levoamphetamine and dextroamphetamine. Amphetamine properly refers to a specific chemical, the racemic free base, which is equal parts of the two enantiomers in their pure amine forms. The term is ...
Canities subita, also called Marie Antoinette syndrome or Thomas More syndrome, is an alleged condition of hair turning white overnight due to stress or trauma. [1] The trivial names come from specific cases in history including that of Queen Marie Antoinette of France whose hair was noted as having turned stark white overnight after her capture following the ill-fated flight to Varennes ...
Amphetamine type stimulants can be used in the treatment of narcolepsy, a rare neurological disorder where the brain is unable to regulate the sleep-wake mechanism. [17] Amphetamines causes an increase in dopamine release, which is the proposed mechanism for its wake-promoting effect. [18]
Male pattern baldness (which can also happen to women and is referred to as female pattern baldness in that case) is the most common form of hair loss. It’s caused by genetic and hormonal ...
Drugs in the class of amphetamines, or substituted amphetamines, are known to induce "amphetamine psychosis" typically when chronically abused or used in high doses. [8] In an Australian study of 309 active methamphetamine users, 18% had experienced a clinical level psychosis in the past year. [9]